At 47c the company has a MC of 87 million. This seems a reasonable valuation considering the anticipated profit growth in FY19, and the following other factors that I do not believe are factored into this profit growth as they are contingent and require further development and discussion:
1. MEG opportunities (very profitable, even though CMP is a gold-standard market competitor, competitors are there)
2. The Somfit China Deal, and other Somfit and product deals (I think in the end the deal will get done, but the revenue and corresponding profit split will not blow the minds of CMP investors, other product deals should be in discussion)
3. Takeover opportunities (CMP is a GLOBAL market leader in neuro and sleep diagnostics, and if the market leaders in this area aren't thinking of consolidating operations then they're absolute f****** morons)
CMP is one of the safest microcap investments I've found. Looking good for the next 1-2 years.
GLTAH and NH. DYOR. NIA.
CMP Price at posting:
49.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)